Cedrus deodara

Cedrus deodara, the Himalayan cedar, contains bioactive sesquiterpenes including himachalol and deodarine that exhibit antimicrobial, anti-inflammatory, and wound-healing properties. These compounds modulate inflammatory pathways and demonstrate antiparasitic activity, particularly against Leishmania donovani, in preclinical models.

Origin & History

Cedrus deodara (Deodar cedar) is a large evergreen coniferous tree native to the western Himalayas, found at altitudes of 1,500-3,200 meters in India, Pakistan, Afghanistan, and Nepal. Extracts are prepared from wood, bark, leaves, and needles using methods such as Soxhlet extraction with various solvents, hydro-distillation for essential oils, or steam distillation for volatile oils.

Historical & Cultural Context

Cedrus deodara has been used in Ayurveda and traditional Himalayan medicine for centuries to treat skin diseases, asthma, neurological disorders, arthritis, microbial infections, gastric disturbances, inflammation, and wounds. While preliminary pharmacology partially validates some traditional uses in preclinical models, human studies are lacking.

Health Benefits

• Wound healing support: Rat studies showed 10% methanol wood extract ointment achieved 93.4% wound contraction after 21 days with improved re-epithelialization (preliminary evidence)
• Anti-parasitic activity: Benzene leaf extract demonstrated antileishmanial effects against Leishmania donovani at 25-200 μg/ml in vitro (preliminary evidence)
• Cancer cell apoptosis: Bark essential oil and total lipids induced programmed cell death in A549 lung cancer cells with G2/M arrest (in vitro evidence only)
• Anti-inflammatory effects: Volatile wood oil showed inflammation reduction in animal models (preliminary evidence)
• Antioxidant properties: Methanol wood extract rich in phenolics and flavonoids demonstrated DPPH radical scavenging activity (in vitro evidence)

How It Works

Himachalol and related sesquiterpene alcohols from Cedrus deodara wood inhibit pro-inflammatory mediators, likely through suppression of COX-2 and NF-κB signaling pathways, reducing oxidative stress at wound sites. The benzene leaf extract's antileishmanial activity is attributed to disruption of the parasite's mitochondrial membrane potential and interference with topoisomerase II enzymes in Leishmania donovani. Deodarine alkaloids also exhibit mild calcium channel antagonism, which may contribute to observed smooth muscle relaxant effects in animal models.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Cedrus deodara. Available evidence is limited to preclinical studies including in vitro assays and animal models, such as the rat wound healing study (n=28) and in vitro antileishmanial studies (PMID: 29664038).

Clinical Summary

Current evidence for Cedrus deodara is limited to preclinical animal and in vitro studies, with no robust human clinical trials published to date. A rat excision wound model demonstrated that a 10% methanol wood extract ointment achieved 93.4% wound contraction over 21 days, with histological confirmation of improved re-epithelialization and collagen deposition compared to controls. In vitro studies using benzene leaf extracts showed antileishmanial activity against Leishmania donovani, though minimum inhibitory concentrations and direct comparisons to standard antileishmanial drugs remain incompletely characterized in available literature. The overall evidence base is preliminary, and extrapolation to human clinical use is not yet scientifically justified.

Nutritional Profile

Cedrus deodara is a non-food medicinal tree; conventional macronutrient/caloric profiling is not applicable. Bioactive compounds are the primary documented constituents: Sesquiterpenes dominate the essential oil fraction, with himachalene isomers (α-himachalene ~10-20%, β-himachalene ~35-50%, γ-himachalene ~8-15%) representing the major volatile components of wood and bark oils. Atlantone (α- and β-atlantone) is a key oxygenated sesquiterpene ketone present in heartwood oil at approximately 5-15%. Himachalol (a sesquiterpene alcohol) is found in wood extracts at reported concentrations of 2-8% of oil fraction. The bark and wood contain diterpenoids including deodarin and dihydrodeodarin (flavanone glycosides). Phenolic compounds identified include quercetin, isorhamnetin, and kaempferol derivatives in leaf and bark extracts at trace to low milligram-per-gram concentrations (approximately 1-5 mg/g dry weight in methanol extracts). Tannins and condensed proanthocyanidins are present in bark at estimated 3-7% dry weight. Fixed oils from seeds contain fatty acids including oleic and linoleic acid. Total phenolic content of bark methanol extract reported at approximately 15-40 mg gallic acid equivalents per gram dry extract. Bioavailability data is largely absent; sesquiterpenes demonstrate lipophilic characteristics suggesting poor aqueous bioavailability without formulation aids. No significant dietary vitamins or minerals have been characterized in pharmacologically relevant concentrations.

Preparation & Dosage

No clinically studied human dosages available. Preclinical studies used: benzene leaf extract at 25-200 μg/ml (standardized to 1.29% linalool) for antileishmanial activity in vitro; 10% (w/w) methanol wood extract ointment applied topically in rats. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Boswellia, Ashwagandha, Gotu Kola, Neem

Safety & Interactions

No well-controlled human safety trials exist for Cedrus deodara supplements, making definitive risk profiling difficult. Animal studies have not reported acute toxicity at standard extract concentrations, but high-dose or prolonged use has not been systematically evaluated for hepatotoxic or nephrotoxic potential. Cedrus deodara essential oil and extracts may potentiate sedative or antihypertensive drugs due to reported calcium channel antagonist activity, warranting caution in patients on such medications. Pregnant and breastfeeding women should avoid supplemental use given the complete absence of safety data in these populations.